Theodoros Koletis

Libytec Pharmaceutical S.A. was established in June 2008 with the unique goal to provide reliable proposals of new pharmaceutical products in the Greek market. Libytec Pharmaceutical S.A. represents, a wide range of products which completely respond to the current needs of the Greek market. The company, covers a remarkable portfolio in many therapeutic categories. Thus, the company provides the Greek Market with high quality pharmaceutical products of advanced therapeutic value and innovative active substances that make a real difference in their category.